Genetic Control of HLA-Linked Immune Responsiveness to Synthethic Polypeptides in Healthy Individuals and Patients with Autoimmune Diseases
The association between the HLA system and susceptibility to various diseases and in particular diseases with immunological disorders is well known . However, the identification of the mechanisms by which various HLA factors cause susceptibility to a variety of diseases is yet to be clarified. The existence of immune response genes and their linkage to the major histocompatibility complex has been established in many species [2, 9, 12]. For a better understanding of HLA and disease associations it is of importance to elucidate the function of immune response (Ir) genes in man. However, in the human, studies on Ir genes have been limited due to genetic heterogeneity of the random population, complexity of the antigens relevant to diseases, constraints of immunization with foreign antigens, and lack of adequate in vitro systems for these studies.
KeywordsSystemic Lupus Erythematosus Major Histocompatibility Complex Systemic Lupus Erythematosus Patient Immune Response Gene Immune Response Potential
Unable to display preview. Download preview PDF.
- 1.Beckmann I (1984) Monoclonal antibodies to HLA-DR antigens. Immunology 5: 29 - 32Google Scholar
- 3.Cohen AS, Reynolds EW, Franklin EC, Kulka JP, Ropes NW, Shulman LE, Wallace SL (1971) Preliminary criteria for the classification of systemic lupus erythematosus. Bull Rheum Dis 21: 643–645Google Scholar
- 4.Fielder AHL, Walport NJ, Batchelor JR, Rynes RI, Black CM, Dodi IA (1983) Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility. Brid Med J 286: 425–428CrossRefGoogle Scholar
- 6.Hsu SH, Chan MM, Bias WB (1981) Genetic control of major histocompatibility complex linked immune responses to synthetic polypeptides in man. Proc Natl Acad Sci USA 125: 352–358Google Scholar
- 14.Talal N (1977) Autoimmunity: genetic, immunologic, virologic, and clinical aspects. Academic, New YorkGoogle Scholar